Black Rock Inc. Talis Biomedical Corp Transaction History

Black Rock Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.44 - $0.54 $2,708 - $3,324	-6,156 Reduced 7.47%	76,307 $36,000
Q1 2023 May 12, 2023	SELL	$0.48 - $0.64 $6,958 - $9,277	-14,496 Reduced 14.95%	82,463 $40,000
Q4 2022 Feb 13, 2023	SELL	$0.45 - $11.67 $112 - $2,917	-250 Reduced 0.26%	96,959 $43,000
Q3 2022 Nov 14, 2022	SELL	$0.7 - $10.79 $3,756 - $57,909	-5,367 Reduced 5.23%	97,209 $65,000
Q2 2022 Aug 12, 2022	SELL	$0.81 - $1.44 $581,917 - $1.03 Million	-718,417 Reduced 87.51%	102,576 $84,000
Q1 2022 May 12, 2022	BUY	$1.3 - $4.19 $6,450 - $20,790	4,962 Added 0.61%	820,993 $1.16 Million
Q4 2021 Feb 10, 2022	BUY	$3.81 - $6.17 $11,026 - $17,855	2,894 Added 0.36%	816,031 $3.27 Million
Q3 2021 Nov 09, 2021	BUY	$6.02 - $12.46 $35,144 - $72,741	5,838 Added 0.72%	813,137 $5.08 Million
Q2 2021 Aug 11, 2021	BUY	$9.62 - $14.56 $7.77 Million - $11.8 Million	807,299 New	807,299 $8.9 Million

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $47.9M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.